The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AGEX THERAPEUTICS INC | COM | 00848H108 | 1,654,130 | 2,997,156 | SH | DFND | 1 | 2,997,156 | 0 | 0 | ||
AXON ENTERPRISE INC | COM | 05464C101 | 126,117,088 | 760,062 | SH | DFND | 1 | 760,062 | 0 | 0 | ||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 120,308,400 | 690,000 | SH | DFND | 1 | 690,000 | 0 | 0 | ||
LINEAGE CELL THERAPEUTICS IN | COM | 53566P109 | 40,874,517 | 34,935,485 | SH | DFND | 1 | 34,935,485 | 0 | 0 | ||
MONSTER BEVERAGE CORP NEW | COM | 61174X109 | 472,773,227 | 4,656,488 | SH | DFND | 1 | 4,656,488 | 0 | 0 | ||
ONCOCYTE CORP | COM | 68235C107 | 7,494,201 | 23,353,697 | SH | DFND | 1 | 23,353,697 | 0 | 0 | ||
STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 426,330,800 | 8,783,082 | SH | DFND | 1 | 8,783,082 | 0 | 0 |